Co-Authors
This is a "connection" page, showing publications co-authored by NATHAN FOWLER and SARINA ANNE PIHA-PAUL.
Connection Strength
0.075
-
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial. J Immunother Cancer. 2018 11 16; 6(1):119.
Score: 0.041
-
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer. Sci Transl Med. 2015 Nov 18; 7(314):314ra185.
Score: 0.033